AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2014
Sep 26, 2014
35086_dirs_2014-09-26_0b843209-5623-4764-ad4c-dde1280e510b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2014-06-30
Reporting Person: Vivaldi Coelho Rogerio (Director, President and CEO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $9.49 | 2023-12-19 | Common Stock (540722) | Direct |
Footnotes
F1: 25% of the shares subject to the option will become exercisable November 1, 2014, and the balance of the option shares will become exercisable in a series of twelve equal quarterly installments upon Dr. Vivaldi's completion of each quarter of service over the three year period thereafter.
F2: This amendment is being filed to correct the following: (a) the exercise price of the option, and (b) the expiration date of the option.
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17